Drugs / GBS III-TT-SSI
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00008853 | ? → Nov 2005 | group B streptococcal infection | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GBS III-TT-SSI | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00008853 ↗ |
| Modality | Vaccine | “anti-streptococcal vaccine” NCT00008853 ↗ |
| Route | Intramuscular | “injection into the muscle” NCT00008853 ↗ |